Can preoperative percutaneous injection of ultrasound contrast agent locate sentinel lymph nodes of breast cancer?

ObjectivesWe evaluated the ability and accuracy of preoperative identification and localization of sentinel lymph nodes (SLNs) using intradermal injection of ultrasound contrast agent.Materials and methodsProspectively recruited 191 early breast cancer patients with clinically negative axillary lymp...

Full description

Saved in:
Bibliographic Details
Main Authors: Dayan Huang, Wenbin Cao, Yunhao Luo, Cheng Guan, Yuyan Liu, Chaonan Li, Jie Chen, Jing Luo, Jun Luo
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-11-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2024.1471443/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850127842180857856
author Dayan Huang
Dayan Huang
Wenbin Cao
Yunhao Luo
Cheng Guan
Yuyan Liu
Yuyan Liu
Chaonan Li
Jie Chen
Jing Luo
Jun Luo
author_facet Dayan Huang
Dayan Huang
Wenbin Cao
Yunhao Luo
Cheng Guan
Yuyan Liu
Yuyan Liu
Chaonan Li
Jie Chen
Jing Luo
Jun Luo
author_sort Dayan Huang
collection DOAJ
description ObjectivesWe evaluated the ability and accuracy of preoperative identification and localization of sentinel lymph nodes (SLNs) using intradermal injection of ultrasound contrast agent.Materials and methodsProspectively recruited 191 early breast cancer patients with clinically negative axillary lymph nodes (ALNs). All participants received intradermal injection of microbubble contrast agent. Following the identification and localization of SLNs using contrast-enhanced ultrasound (CEUS), Markers were deployed in the SLNs US-guided. Subsequently, the SLNs with Markers were stained and marked with a suspension of nano-carbon US-guided to assist in intraoperative localization of SLNs. Standard SLNB with methylene blue tracing was performed intraoperatively to assess the consistency between the two methods of SLNs localization, thereby determining the ability and accuracy of CEUS in identifying and localizing SLNs.ResultsA total of 179 patients were included in the final evaluation analysis, in which a microbubble contrast agent was injected subcutaneously in the areolar region. A total of 201 SLNs were identified, with a median of 1 SLN per patient. Each SLN was identified in 157 patients, and two SLNs were identified in 22 patients. Among the 201 SLNs from the 179 patients, the proportion that could be individually matched between CEUS and the blue dye method was 95.5% (192/201), and the consistency evaluation in SLNs identification between CEUS and blue dye staining was excellent (Kappa value = 0.62, P < 0.001).ConclusionThe consistency of identification and localization of SLNs in early breast cancer patients between CEUS and the blue dye method was strong.
format Article
id doaj-art-bfad944d2c3947e193bee854b7314d57
institution OA Journals
issn 2234-943X
language English
publishDate 2024-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj-art-bfad944d2c3947e193bee854b7314d572025-08-20T02:33:34ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2024-11-011410.3389/fonc.2024.14714431471443Can preoperative percutaneous injection of ultrasound contrast agent locate sentinel lymph nodes of breast cancer?Dayan Huang0Dayan Huang1Wenbin Cao2Yunhao Luo3Cheng Guan4Yuyan Liu5Yuyan Liu6Chaonan Li7Jie Chen8Jing Luo9Jun Luo10School of Medicine, University of Electronic Science and Technology of China, Chengdu, ChinaDepartment of Ultrasound, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, ChinaDepartment of Ultrasound, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, ChinaSchool of Medical and Life Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, ChinaSchool of Medical and Life Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, ChinaSchool of Medicine, University of Electronic Science and Technology of China, Chengdu, ChinaDepartment of Ultrasound, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, ChinaSchool of Medical and Life Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, ChinaDepartment of Breast Surgery, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, ChinaDepartment of Breast Surgery, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, ChinaDepartment of Ultrasound, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, ChinaObjectivesWe evaluated the ability and accuracy of preoperative identification and localization of sentinel lymph nodes (SLNs) using intradermal injection of ultrasound contrast agent.Materials and methodsProspectively recruited 191 early breast cancer patients with clinically negative axillary lymph nodes (ALNs). All participants received intradermal injection of microbubble contrast agent. Following the identification and localization of SLNs using contrast-enhanced ultrasound (CEUS), Markers were deployed in the SLNs US-guided. Subsequently, the SLNs with Markers were stained and marked with a suspension of nano-carbon US-guided to assist in intraoperative localization of SLNs. Standard SLNB with methylene blue tracing was performed intraoperatively to assess the consistency between the two methods of SLNs localization, thereby determining the ability and accuracy of CEUS in identifying and localizing SLNs.ResultsA total of 179 patients were included in the final evaluation analysis, in which a microbubble contrast agent was injected subcutaneously in the areolar region. A total of 201 SLNs were identified, with a median of 1 SLN per patient. Each SLN was identified in 157 patients, and two SLNs were identified in 22 patients. Among the 201 SLNs from the 179 patients, the proportion that could be individually matched between CEUS and the blue dye method was 95.5% (192/201), and the consistency evaluation in SLNs identification between CEUS and blue dye staining was excellent (Kappa value = 0.62, P < 0.001).ConclusionThe consistency of identification and localization of SLNs in early breast cancer patients between CEUS and the blue dye method was strong.https://www.frontiersin.org/articles/10.3389/fonc.2024.1471443/fullbreast cancercontrast-enhanced ultrasoundsentinel lymph nodemarkernanocarbon
spellingShingle Dayan Huang
Dayan Huang
Wenbin Cao
Yunhao Luo
Cheng Guan
Yuyan Liu
Yuyan Liu
Chaonan Li
Jie Chen
Jing Luo
Jun Luo
Can preoperative percutaneous injection of ultrasound contrast agent locate sentinel lymph nodes of breast cancer?
Frontiers in Oncology
breast cancer
contrast-enhanced ultrasound
sentinel lymph node
marker
nanocarbon
title Can preoperative percutaneous injection of ultrasound contrast agent locate sentinel lymph nodes of breast cancer?
title_full Can preoperative percutaneous injection of ultrasound contrast agent locate sentinel lymph nodes of breast cancer?
title_fullStr Can preoperative percutaneous injection of ultrasound contrast agent locate sentinel lymph nodes of breast cancer?
title_full_unstemmed Can preoperative percutaneous injection of ultrasound contrast agent locate sentinel lymph nodes of breast cancer?
title_short Can preoperative percutaneous injection of ultrasound contrast agent locate sentinel lymph nodes of breast cancer?
title_sort can preoperative percutaneous injection of ultrasound contrast agent locate sentinel lymph nodes of breast cancer
topic breast cancer
contrast-enhanced ultrasound
sentinel lymph node
marker
nanocarbon
url https://www.frontiersin.org/articles/10.3389/fonc.2024.1471443/full
work_keys_str_mv AT dayanhuang canpreoperativepercutaneousinjectionofultrasoundcontrastagentlocatesentinellymphnodesofbreastcancer
AT dayanhuang canpreoperativepercutaneousinjectionofultrasoundcontrastagentlocatesentinellymphnodesofbreastcancer
AT wenbincao canpreoperativepercutaneousinjectionofultrasoundcontrastagentlocatesentinellymphnodesofbreastcancer
AT yunhaoluo canpreoperativepercutaneousinjectionofultrasoundcontrastagentlocatesentinellymphnodesofbreastcancer
AT chengguan canpreoperativepercutaneousinjectionofultrasoundcontrastagentlocatesentinellymphnodesofbreastcancer
AT yuyanliu canpreoperativepercutaneousinjectionofultrasoundcontrastagentlocatesentinellymphnodesofbreastcancer
AT yuyanliu canpreoperativepercutaneousinjectionofultrasoundcontrastagentlocatesentinellymphnodesofbreastcancer
AT chaonanli canpreoperativepercutaneousinjectionofultrasoundcontrastagentlocatesentinellymphnodesofbreastcancer
AT jiechen canpreoperativepercutaneousinjectionofultrasoundcontrastagentlocatesentinellymphnodesofbreastcancer
AT jingluo canpreoperativepercutaneousinjectionofultrasoundcontrastagentlocatesentinellymphnodesofbreastcancer
AT junluo canpreoperativepercutaneousinjectionofultrasoundcontrastagentlocatesentinellymphnodesofbreastcancer